Trend-Following Backtester · Guide · backtest 한국어

equity · US

Syndax Pharmaceuticals, Inc. backtest

10 trend-following strategies were compared on the full daily history of Syndax Pharmaceuticals, Inc.. 2 beat buy-and-hold CAGR; MACD ranks first by Sharpe, matching the main backtester.

Data 2016-03-02 ~ 2026-07-31daily bars 2,619 (10.4 years)Costs 0.5%Venue XNASMonthly snapshot 2026-07-31

Results by strategy

2 of 10 beat buy and hold (CAGR 4.5%, drawdown -79.0%).

Sharpe leader (same as main): MACD — CAGR 13.8%, MDD -71.7%, Sharpe 0.50, 48% exposure.

No strategy retained at least 75% of buy-and-hold CAGR while reducing drawdown by both 20% relatively and 5 percentage points absolutely.

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
MACD
fast=15, slow=39, signal=10
13.8%-71.7%0.500.193.9x13448%
Supertrend
period=19, mult=1.8
8.0%-76.1%0.390.112.2x12249%
Donchian 채널 돌파
entryN=2, exitN=26
1.5%-78.0%0.330.021.2x10384%
SMA 크로스오버
fast=59, slow=169
3.1%-67.1%0.300.051.4x1847%
ROC 모멘텀
n=99, threshold=0.1
-0.3%-69.2%0.21-0.001.0x8438%
Parabolic SAR
step=0.015, maxStep=0.24
-5.1%-83.1%0.16-0.060.6x19248%
ADX / DI 방향성
period=27, threshold=11
-6.1%-84.6%0.10-0.070.5x11646%
EMA 크로스오버
fast=56, slow=216
-7.5%-79.9%0.09-0.090.4x2148%
Keltner 채널 돌파
emaPeriod=45, atrPeriod=13, mult=1.5
-9.3%-77.7%-0.02-0.120.4x7434%
볼린저 밴드 돌파
n=36, k=3.4
-3.0%-59.2%-0.08-0.050.7x168%
Buy and hold4.5%-79.0%0.410.061.6x1100%
1x 2017 2019 2021 2023 2025 MACDBuy and hold
MACD: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -20% -39% -59% -79% 2017 2019 2021 2023 2025 Buy and holdMACD
MACD maximum drawdown -71.7% (2018-03-26 → 2020-04-21), recovered after 2,089 days.

Rules of the top strategy

Looks at the gap (MACD) between a short and long average crossing its own signal line.

Method and caveats

Past performance does not guarantee future returns. Parameters were carried forward from the latest full optimization and replayed on this monthly dataset. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-optimize the same period and setupAll asset reports

Read next